Opposing Effects of C-Reactive Protein Isoforms on Shear-Induced Neutrophil-Platelet Adhesion and Neutrophil Aggregation in Whole Blood
- 26 October 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 110 (17), 2713-2720
- https://doi.org/10.1161/01.cir.0000146846.00816.dd
Abstract
Background—Plasma C-reactive protein (CRP) level is a powerful predictor of cardiovascular events. However, it is not known whether CRP could affect neutrophil-platelet adhesion and neutrophil aggregation, key events in acute coronary syndromes. Emerging in vitro evidence suggests that some bioactivities of CRP are expressed on loss of the pentameric symmetry, resulting in formation of modified or monomeric CRP (mCRP).Methods and Results—We studied the impact of human native CRP and bioengineered mCRP that cannot rearrange into the pentameric structure on the kinetics of neutrophil-platelet adhesion and neutrophil aggregation in whole blood subjected to shear (≈100 s−1) using real-time flow cytometry. Shear resulted in upregulation of platelet P-selectin expression, leading to platelet capture of neutrophils and subsequent neutrophil aggregation, which was dependent on P-selectin, L-selectin, and CD18. Native CRP at clinically relevant concentrations markedly attenuated these changes. The residual amount of neutrophil adhesion was blocked with anti-CD18 or anti-CD11b antibody. By contrast, mCRP concentration-dependently enhanced shear-induced platelet P-selectin expression and increased the rate and extent of formation of both neutrophil-platelet and neutrophil-neutrophil aggregates. Complete abrogation of platelet-neutrophil adhesion and neutrophil aggregation required both anti-P-selectin and anti-CD18 antibodies but not anti-L-selectin antibody. The CRP action was markedly inhibited by an anti-CD32 antibody, whereas the mCRP effects were significantly attenuated by an anti-CD16 antibody.Conclusions—These results indicate that native CRP inhibits platelet activation and prevents platelet capture of neutrophils, whereas mCRP displays potent prothrombotic activities under low levels of shear. Thus, mCRP rather than native CRP may precipitate acute coronary syndromes.Keywords
This publication has 30 references indexed in Scilit:
- Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle CellsCirculation, 2003
- Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary SyndromesCirculation, 2003
- Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic MiceCirculation, 2003
- Loss of Pentameric Symmetry of C-reactive Protein Is Associated with Delayed Apoptosis of Human NeutrophilsPublished by Elsevier BV ,2002
- The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1The Journal of Experimental Medicine, 2002
- Dissociation and Subunit Rearrangement of Membrane-Bound Human C-Reactive ProteinsBiochemical and Biophysical Research Communications, 2001
- Evaluation of circulating platelet–leukocyte conjugates: a sensitive flow cytometric assay well suited for clinical studiesPlatelets, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?Journal of the American College of Cardiology, 1996
- Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunitMolecular Immunology, 1987